Lopid

Functionalized magnetic carbonaceous nanomaterials, which are important materials with many practical and research applications… (More)

Renal and hepatic subacute toxicity induced by the antihyperlipidaemic drugs: Bezalip-Pravastatin and Lopid was investigated in… (More)

Hyperlipidemia is a common side-effect of oral retinoid treatment, which sometimes interferes with long-term therapy. To evaluate… (More)

Our specific aim was to assess severe hypertriglyceridemia and pancreatitis that occurred when postmenopausal estrogen… (More)

This randomized, parallel-group, multicenter clinical trial compared a newly developed, once-daily, extended-release formulation… (More)

If the iatrogenic acute muscular syndromes (rhabdomyolysis) and hepatic diseases following hypolipidemic drugs therapy are very… (More)

Sensitive and specific methods for the simultaneous determination of gemfibrozil (Lopid), a lipid-lowering agent, and its… (More)

Thirteen patients with phenotypic type V hyperlipidemia were treated with either gemfibrozil (Lopid) or a placebo in a randomized… (More)

Gemfibrozil (Lopid) is a new plasma lipid-regulating drug that decreases very low and low density lipoprotein (VLD/LDL) and… (More)

This report describes the results of long-term treatment for blood lipid regulation with a new drug, gemfibrozil (Lopid). During… (More)